CORAZZA, Laura
 Distribuzione geografica
Continente #
NA - Nord America 304
AS - Asia 75
EU - Europa 66
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 12
Totale 469
Nazione #
US - Stati Uniti d'America 301
SG - Singapore 36
UA - Ucraina 19
CN - Cina 13
DE - Germania 13
IT - Italia 12
BR - Brasile 11
HK - Hong Kong 9
IN - India 7
FI - Finlandia 6
FR - Francia 4
IE - Irlanda 3
IQ - Iraq 3
NL - Olanda 3
VN - Vietnam 3
GB - Regno Unito 2
JP - Giappone 2
RU - Federazione Russa 2
CA - Canada 1
CO - Colombia 1
ES - Italia 1
GT - Guatemala 1
MX - Messico 1
PK - Pakistan 1
SE - Svezia 1
TR - Turchia 1
Totale 457
Città #
Ann Arbor 80
Woodbridge 35
Chandler 20
Singapore 16
Fairfield 14
Ashburn 12
Jacksonville 12
Dearborn 9
Hong Kong 9
Seattle 9
Beijing 8
Wilmington 7
Boardman 6
Houston 6
Udine 6
San Jose 5
Cambridge 4
Los Angeles 4
Council Bluffs 3
Dublin 3
Lauterbourg 3
Munich 3
Pisa 3
Princeton 3
São Paulo 3
Amsterdam 2
Buffalo 2
Dallas 2
Des Moines 2
Frankfurt am Main 2
New Delhi 2
Norwalk 2
Philadelphia 2
Salerno 2
São Luís 2
Ahmedabad 1
Ankara 1
Aracaju 1
Atlanta 1
Birmingham 1
Boerne 1
Canton 1
Cardiff 1
Chennai 1
Cúcuta 1
Duhok 1
Erbil 1
Fort Mill 1
Freehold 1
Guareí 1
Guatemala City 1
Haiphong 1
Hangzhou 1
Helsinki 1
Ho Chi Minh City 1
Huntsville 1
Ilhéus 1
Indiana 1
Madrid 1
Malden 1
Minneapolis 1
Montreal 1
Nasiriyah 1
New York 1
Nihon'odori 1
Orem 1
Paris 1
Pelham 1
Phoenix 1
Redondo Beach 1
Rohtak 1
Sabará 1
Salt Lake City 1
San Antonio 1
San Diego 1
Schenectady 1
Shanghai 1
Sialkot 1
São Gonçalo 1
São José do Rio Preto 1
Trieste 1
Umeda 1
Washington 1
Totale 351
Nome #
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 175
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 153
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 141
Totale 469
Categoria #
all - tutte 1.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 0 3 1 2 0 3 3 1 12 3
2022/202349 3 4 0 7 5 13 0 4 8 0 2 3
2023/202410 1 2 0 1 0 0 0 0 0 0 6 0
2024/202550 3 10 3 7 0 3 0 3 5 2 4 10
2025/202670 6 9 5 0 12 9 5 1 8 4 6 5
2026/202731 4 17 10 0 0 0 0 0 0 0 0 0
Totale 469